Ph II Cabazitaxel DD Liposarcoma

Clinical trial NCT01913652 · COMPLETED

Trial details

NCT number: NCT01913652
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dedifferentiated Liposarcoma

Start date: 2014-10-01
Primary completion: 2020-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.